Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
stents
Submitted by
admin
on Thu, 05/06/2010 - 14:05
Device News
A Win for Medtech in Stent vs. Surgery Debate
Minyanville
Abbott Laboratories
Boston Scientific
JNJ
Medtronic
stents
»
4 comments
Submitted by
admin
on Mon, 05/03/2010 - 13:15
Device News
Arterial Remodeling Technologies ("ART") to disclose new data about its bioresorbable stent at the 9th annual 'EBR Symposium 2010', May 6th
EarthTimes
angioplasty
Arterial Remodeling Technologies
bioresorbable stent
stents
»
Login
or
register
to post comments
News
Who Needs Drug Studies?
Forbes
Abbott Laboratories
clinical trials
stents
TriCor
»
2 comments
News
Stroke study finds neck stents safe, effective
Yahoo/AP
stents
»
3 comments
News
Boston Sci to pay J&J $1.7 bln in patent dispute
Marketwatch
Boston Scientific
JNJ
settlements
stents
»
Login
or
register
to post comments
News
Lawsuit Challenges Marketing of Stents
NY Times, NY
Boston Scientific
Guidant
JNJ
lawsuits
stents
»
Login
or
register
to post comments
News
New Market for Abbott's XIENCE V
Yahoo/Zacks.com
Abbott Laboratories
Japan
stents
Xience
»
3 comments
News
Abbott's Stent Struggling to Maintain Market Share
Minyanville
Abbott Laboratories
stents
»
2 comments
News
Boston Scientific Stent Shouldn’t Be Used Regularly, Study Says
Bloomberg
Boston Scientific
stents
»
Login
or
register
to post comments
News
Medtronic's Passion Play: Medical device maker to test stent as alternative to Viagra
Forbes
erectile dysfunction
Medtronic
stents
Viagra
»
123 comments
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT